Pierre Fabre is a French privately-owned health and beauty care company created in 1961 by Mr. Pierre Fabre. In 2014, global sales reached €2.1 billion across 130 countries. The company is structured around two divisions: Pharmaceuticals (Prescription drugs, Consumer HealthCare) and Dermo-cosmetics (including the European and Asian market leader Eau Thermale Avène brand). Pierre Fabre employs some 10,000 people worldwide and owns subsidiary in 43 countries. In 2014, the company allocated 17 percent of its pharmaceuticals sales to R&D with a focus on 4 therapeutic areas: oncology, dermatology, CNS and consumer healthcare.
Pierre Fabre's oncology know-how is based on 3 decades of experience in the discovery, development and global commercialization of innovative cancer drugs including monoclonal antibodies and natural cytotoxic agents. The company performs its oncology R&D in two major research centres: the Pierre Fabre Immunology Centre (CIPF) based in Saint-Julien-en-Genevois (France) and the Pierre Fabre Research- Centre (CRPF) located on the Toulouse Oncopole campus. The latter is officially recognized by the French government as a National Center of Excellence for cancer research. For more information on Pierre Fabre, please visit www.pierre-fabre.com.
The University of Wisconsin–Madison is a public research university in Madison, Wisconsin, United States. Founded when Wisconsin achieved statehood in 1848, UW–Madison is the official state university of Wisconsin, and the flagship campus of the University of Wisconsin System. The UW is one of America's Public Ivy universities, which refers to top universities in the United States capable of providing a collegiate experience comparable with the Ivy League. UW–Madison is also categorized as an RU/VH Research University (very high research activity) in the Carnegie Classification of Institutions of Higher Education. In 2012, it had research expenditures of more than $1.1 billion, the third highest among universities in the country. For more information on the university, please visit www.wisc.edu.
The Wisconsin Alumni Research Foundation (WARF) is the private, nonprofit patent and licensing organization for the University of Wisconsin–Madison, one of the world’s great research universities. WARF was founded in 1925 and is a pioneer and innovator among university-based technology transfer offices. For more information about the Wisconsin Alumni Research Foundation, please visit www.warf.org.
Based in Basel, Switzerland, Avicenna Oncology was founded with the purpose of combining precision medicine with drug conjugates to treat resistant cancers. Led by an experienced team and funded by serial entrepreneurs, the company builds on its international network of collaborations and promising programs to overcome the limitations of current chemotherapies and targeted therapeutics for which many cancers have developed resistance mechanisms. For more information on Avicenna Oncology, please visit www.avicenna-oncology.com.